Position in PFE
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,368,610
-$306,333 QoQ
Shares Held
56,836
-4.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#1,137
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Community Bank & Trust, Waco, Texas holds $34,263,399 across 8 Drug Manufacturers - General names. PFE ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
53,272 | $13,529,489 | |
| 2 | ABBV |
AbbVie Inc.
|
33,072 | $8,322,238 | |
| 3 | MRK |
Merck & Co., Inc.
|
39,889 | $5,125,736 | |
| 4 | AMGN |
Amgen Inc
|
10,604 | $3,839,920 | |
| 5 | PFE |
Pfizer Inc
This page
|
56,836 | $1,368,610 | |
| 6 | AZN |
Astrazeneca PLC
|
5,367 | $1,017,690 | |
| 7 | LLY |
ELI LILLY & Co
|
511 | $612,908 | |
| 8 | NVS |
Novartis AG
|
2,851 | $446,808 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,368,610 | 56,836 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,674,943 | 59,649 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,532,868 | 61,561 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,703,108 | 66,841 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,610,238 | 66,429 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,701,530 | 67,148 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,894,374 | 71,405 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $2,136,032 | 73,809 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,239,295 | 80,032 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,301,057 | 82,921 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,431,200 | 84,446 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $5,943 | 135,799 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $4,828,445 | 131,637 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,466,384 | 133,980 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $6,930,005 | 135,246 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,942,564 | 135,799 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $7,282,579 | 138,901 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,162,793 | 138,358 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $7,959,821 | 134,798 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $5,882,176 | 136,763 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,350,509 | 136,632 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $4,842,900 | 133,671 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $4,467,187 | 121,358 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $4,295,620 | 117,047 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,614,759 | 110,543 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $3,646,340 | 111,714 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||